PSC code
R&D- MEDICAL: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- PSC code
- AN92
- Latest action
- Jul 8, 2026
Fewer than the minimum comparable awards under this PSC code.
Largest awards under this code
| Award | Contractor | Agency | Place | First action | Current value |
|---|---|---|---|---|---|
| HHSO100201700026C THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE CANCELLING FUNDS IN THE AMOUNT OF $2,539,496.23 AS FOLLOWS: 1. $1,050,656.17 FROM CLIN 0013 2. $1,488,840.00 FROM CLIN 0014 3. $0.06 FROM CLIN 0012 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Health and Human Services | NJ | Jul 8, 2026 | $16,334,775 |
| W81XWH19C0096 PROPOSAL BA 180365 ENTITLED, ADDRESSING SIGNAL LATENCY AND SIGNAL LOSS IN TELEROBOTIC TASKS USING MACHINE LEARNING AND SEMI-AUTONOMOUS ROBOTIC PROTOCOLS TO IMPROVE SAFETY AND EFFICIENCY, WHICH IS INCORPORATED BY REFERENCE. | SRI INTERNATIONAL | Department of Defense | CA | Apr 13, 2026 | $6,415,851 |
Related records
Derived from awards these records share, ordered by how many.
Performed in
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals cover awards where the government recorded this PSC code. Codes are taken as reported; awards are never reclassified into a different code.
- 1Awards are grouped by the PSC code the government recorded on the award, taken from USAspending.gov and last refreshed Aug 10, 2026. Miscoded awards stay miscoded here; we do not reassign codes.